Product Code: ETC8848135 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Philippines Partial Androgen Insensitivity Syndrome (PAIS) market is expanding as awareness of genetic disorders and hormonal imbalances increases. PAIS is a condition where individuals have partial resistance to androgens, leading to a range of physical manifestations. Treatment typically involves hormone replacement therapy and surgical interventions. As genetic testing becomes more widely available, early diagnosis and tailored treatment options are expected to drive growth in this market.
The market for Partial Androgen Insensitivity Syndrome (PAIS) treatment in the Philippines is growing, driven by increasing awareness of the condition and advancements in medical treatments. PAIS is a genetic disorder that affects male sexual development, causing partial resistance to androgens (male hormones). While rare, the rising demand for genetic testing, early diagnosis, and appropriate management therapies is pushing the market forward. Healthcare facilities are adopting better diagnostic tools and hormone therapies to manage symptoms, and as medical knowledge expands, the availability of more personalized treatments is expected to drive the markets growth.
Cultural and societal stigma around intersex conditions like PAIS complicates diagnosis and care. Endocrinological and genetic testing is limited to a few facilities, and there is a lack of multidisciplinary care frameworks. Psychological support for affected individuals is often absent.
The Philippines Partial Androgen Insensitivity Syndrome (PAIS) market is growing as the recognition of PAIS, a genetic disorder affecting sexual development, becomes more widespread. People with PAIS may experience a range of symptoms, including ambiguous genitalia and infertility. The market for PAIS-related treatments is expanding, with opportunities for genetic counseling, hormone therapy, and surgical options to address the condition. As healthcare providers continue to improve their understanding of PAIS, there are opportunities for investors to develop and distribute targeted treatments that cater to the unique needs of individuals with partial androgen insensitivity.
The Philippine government has made efforts to address conditions such as Partial Androgen Insensitivity Syndrome (PAIS) through healthcare policies aimed at improving access to gender-related health services. Policies focus on raising awareness about genetic disorders and promoting specialized treatment for those with PAIS, including hormone therapy and surgical interventions. The government also provides support for the development of healthcare resources and facilities that cater to individuals with gender dysphoria and related conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Partial Androgen Insensitivity Syndrome Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Partial Androgen Insensitivity Syndrome Market - Industry Life Cycle |
3.4 Philippines Partial Androgen Insensitivity Syndrome Market - Porter's Five Forces |
3.5 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.7 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Partial Androgen Insensitivity Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Partial Androgen Insensitivity Syndrome Market Trends |
6 Philippines Partial Androgen Insensitivity Syndrome Market, By Types |
6.1 Philippines Partial Androgen Insensitivity Syndrome Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.4 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Estrogen or Testosterone Therapy, 2021- 2031F |
6.1.5 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Partial Androgen Insensitivity Syndrome Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Injectables, 2021- 2031F |
6.2.3 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Partial Androgen Insensitivity Syndrome Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4 Philippines Partial Androgen Insensitivity Syndrome Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Philippines Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Partial Androgen Insensitivity Syndrome Market Import-Export Trade Statistics |
7.1 Philippines Partial Androgen Insensitivity Syndrome Market Export to Major Countries |
7.2 Philippines Partial Androgen Insensitivity Syndrome Market Imports from Major Countries |
8 Philippines Partial Androgen Insensitivity Syndrome Market Key Performance Indicators |
9 Philippines Partial Androgen Insensitivity Syndrome Market - Opportunity Assessment |
9.1 Philippines Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Philippines Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.3 Philippines Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Philippines Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Partial Androgen Insensitivity Syndrome Market - Competitive Landscape |
10.1 Philippines Partial Androgen Insensitivity Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Philippines Partial Androgen Insensitivity Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |